Life Science: Great Promise & Rapid Growth

TOP VC-FUNDED COMPANIES (2018)

COMPANY

ROUND

MONEY RAISED LEAD INVESTORS

Prevail Therapeutics

Series A

$75M

OrbiMed, PontifaxFund, RA Capital Management

Kallyope

Series B

$66M

Lux Capital

Gotham Therapeutics

Series A

$54M

SR One, Versant Venture Management, Forbion Capital Partners

Quentis Therapeutics

Series A

$48M

Versant Venture Management, Polaris Partners

Care/of

Series B

$29M

Goldman Sachs

Attune Pharmaceuticals

Series B

$23M

RA Capital Management

Celmatix

Later Stage VC $23M

Undisclosed

HealthReveal

Series A

$16M

GE Ventures

Angion Biomedica

Later Stage VC $15M

Undisclosed

AccutarBiotechnology

Series A3

$12M

Yitu, Zhen Partners Management, IDG Capital

MevesPharmaceuticals

Series A1

F-Prime Capital Partners, Orbimed

$11M

MouSensor

Alexandria Venture Investments, imec.xpand

Seed Funding

$3M

Source: PitchBook, Crunchbase

RENT VS. VACANCY COMPARISON

NOTABLE LEASE TRANSACTIONS (2018)

$60 $62 $64 $66 $68 $70 $72 $74 $76 $78 $80

24%

Bristol-Myers Squibb (HQ)

TENANT

20%

SF

15,000

16%

LANDLORD

Alexandria

12%

ADDRESS

Alexandria Center

8%

SUBMARKET

Madison/ Union Square

4%

LEASE TYPE

New Lease

0%

2014

2015

2016

2017

2018

Asking Rent, $ PSF (NNN)

Overall Vacancy Rate

NOTABLE SALE TRANSACTIONS (2017 - 2018)

SUBMARKET STATS

219 East 42nd St

30-02 48th Ave

ADDRESS

AVG. ASKING RENT (NNN)

INVENTORY (SF)

VACANCY

SUBMARKET

Grand Central

Long Island City

Madison/Union Square

N/A

739,434

0.0%

SF

350,000

177,000

West Side

$79.00

167,422

75.4%

BUYER

JV between: David Werner Real Estate, Alexandria Real Estate Equities, Deutsche Bank AG

Alexandria Real Estate Equities

Brooklyn

N/A

94,000

0.0%

Long Island City

N/A

176,759

77.2%

SELLER

Pfizer Inc.

Brickman Real Estate

PRICE

$205,000,000

$75,000,000

TENANTS

Leaseback

Shapeways

23

Contributors: Michael Miceli, michael.miceli@cushwake.com; Marc Kunesch, marc.kunesch@cushwake.com